Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

Table 3

BPRS score throughout the study (scores presented as mean [SD] values).

Visit	Amisulpride group	Olanzapine group
1	54.7 [5.92]	57.5 [7.73]
2	47.1 [5.72]	49.3 [7.20]
3	37.9 [6.81]	42.2 [7.74]
Mean change from baseline	16.8 [3.61]	15.3 [2.69]